Multi-Institutional Analysis of Synchronous Prostate and Rectosigmoid Cancers

Conclusions: Synchronous rectosigmoid cancer is a greater contributor to mortality than prostate cancer. Men aged ≥45 with localized prostate cancer should undergo colorectal cancer screening prior to treatment to evaluate for synchronous rectosigmoid cancer.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research